Neuronetics (STIM) Income towards Parent Company (2017 - 2026)
Neuronetics (STIM) posted quarterly Income towards Parent Company of -$11.3 million for Q1 2026, up 13.96% year-over-year from -$9.9 million in Q1 2025, and down 51.48% quarter-over-quarter from -$7.4 million in Q4 2025.
Neuronetics (STIM) Income towards Parent Company (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Income towards Parent Company for 10 consecutive years, with -$11.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company rose 13.96% year-over-year to -$11.3 million; the TTM figure through Mar 2026 stood at -$49.0 million (down 4.21% YoY), while the FY2025 annual figure was -$39.9 million, up 76.36% from the prior year.
- Income towards Parent Company fell to -$11.3 million in Q1 2026 per STIM's latest filing, from -$7.4 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$6.1 million in Q4 2023 and bottomed at -$18.2 million in Q2 2025.
- Historically, Income towards Parent Company has averaged -$10.8 million across 5 years, with a median of -$10.6 million in 2024.
- Annual changes were most pronounced in 2022 — Income towards Parent Company jumped 56.22% — and 2024, when it slumped 127.29%.
- Neuronetics' Income towards Parent Company stood at -$8.8 million in 2022, then jumped by 30.93% to -$6.1 million in 2023, then tumbled by 127.29% to -$13.9 million in 2024, then surged by 46.36% to -$7.4 million in 2025, then tumbled by 51.48% to -$11.3 million in 2026.
- Business Quant data shows STIM's Income towards Parent Company at -$11.3 million in Q1 2026, -$7.4 million in Q4 2025, and -$12.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Neuronetics | 229.99 Mn | 210.56 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.10 Mn |
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -7.43 Mn |
| Sep 30, 2025 | -12.10 Mn |
| Jun 30, 2025 | -18.19 Mn |
| Mar 31, 2025 | -13.09 Mn |
| Dec 31, 2024 | -13.86 Mn |
| Sep 30, 2024 | -9.45 Mn |
| Jun 30, 2024 | -10.61 Mn |
| Mar 31, 2024 | -8.69 Mn |
| Dec 31, 2023 | -6.10 Mn |
| Sep 30, 2023 | -10.06 Mn |
| Jun 30, 2023 | -8.35 Mn |
| Mar 31, 2023 | -11.16 Mn |
| Dec 31, 2022 | -8.83 Mn |
| Sep 30, 2022 | -8.71 Mn |
| Jun 30, 2022 | -11.09 Mn |
| Mar 31, 2022 | -15.27 Mn |
| Dec 31, 2021 | -7.74 Mn |
| Sep 30, 2021 | -12.79 Mn |